Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomes.
Cardiovascular disease
Chronic kidney disease
Diabetes
GLP-1 receptor agonist
Heart failure
Living guidelines
Mineralocorticoid receptor antagonist
Obesity
SGLT2 inhibitor
Tirzepatide
Journal
Cardiovascular diabetology
ISSN: 1475-2840
Titre abrégé: Cardiovasc Diabetol
Pays: England
ID NLM: 101147637
Informations de publication
Date de publication:
08 04 2022
08 04 2022
Historique:
received:
08
03
2022
accepted:
14
03
2022
entrez:
9
4
2022
pubmed:
10
4
2022
medline:
13
4
2022
Statut:
epublish
Résumé
The 7th Cardiovascular Outcome Trial (CVOT) Summit on Cardiovascular, Renal, and Glycemic Outcomes, was held virtually on November 18-19, 2021. Pursuing the tradition of the previous summits, this reference congress served as a platform for in-depth discussion and exchange on recently completed CVOTs. This year's focus was placed on the outcomes of EMPEROR-Preserved, FIGARO-DKD, AMPLITUDE-O, SURPASS 1-5, and STEP 1-5. Trial implications for diabetes and obesity management and the impact on new treatment algorithms were highlighted for endocrinologists, diabetologists, cardiologists, nephrologists, and general practitioners. Discussions evolved from outcome trials using SGLT2 inhibitors as therapy for heart failure, to CVOTs with nonsteroidal mineralocorticoid receptor antagonists and GLP-1 receptor agonists. Furthermore, trials for glycemic and overweight/obesity management, challenges in diabetes management in COVID-19, and novel guidelines and treatment strategies were discussed.Trial registration The 8th Cardiovascular Outcome Trial Summit will be held virtually on November 10-11, 2022 ( http://www.cvot.org ).
Identifiants
pubmed: 35395808
doi: 10.1186/s12933-022-01481-0
pii: 10.1186/s12933-022-01481-0
pmc: PMC8990484
doi:
Substances chimiques
Blood Glucose
0
Hypoglycemic Agents
0
Sodium-Glucose Transporter 2 Inhibitors
0
Types de publication
Congress
Letter
Langues
eng
Sous-ensembles de citation
IM
Pagination
50Informations de copyright
© 2022. The Author(s).
Références
N Engl J Med. 2021 Aug 5;385(6):503-515
pubmed: 34170647
Lancet. 2018 Oct 27;392(10157):1519-1529
pubmed: 30291013
N Engl J Med. 2016 Nov 10;375(19):1834-1844
pubmed: 27633186
Rheumatology (Oxford). 2017 Aug 1;56(suppl_4):iv14-iv29
pubmed: 28903544
AAPS J. 2016 May;18(3):670-7
pubmed: 26873509
Eur J Heart Fail. 2021 Jun;23(6):872-881
pubmed: 33932268
Eur J Heart Fail. 2019 Oct;21(10):1279-1287
pubmed: 31523904
N Engl J Med. 1993 Sep 30;329(14):977-86
pubmed: 8366922
Diabetes Care. 2019 Mar;42(3):400-405
pubmed: 30352896
J Clin Pathol. 2019 Jan;72(1):12-19
pubmed: 30361394
Cardiovasc Diabetol. 2016 Feb 18;15:33
pubmed: 26892706
N Engl J Med. 2013 Oct 3;369(14):1327-35
pubmed: 23992602
N Engl J Med. 2019 Jan 24;380(4):347-357
pubmed: 30415602
Eur Heart J. 2022 Feb 10;43(6):474-484
pubmed: 35023547
N Engl J Med. 2020 Oct 8;383(15):1436-1446
pubmed: 32970396
Lancet Diabetes Endocrinol. 2020 Jun;8(6):546-550
pubmed: 32334646
BMJ. 2020 Sep 4;370:m3379
pubmed: 32887691
Lancet Diabetes Endocrinol. 2021 Sep;9(9):586-594
pubmed: 34302745
Kidney Int. 2017 Aug;92(2):388-396
pubmed: 28577854
N Engl J Med. 2020 Oct 8;383(15):1413-1424
pubmed: 32865377
Lancet. 1998 Sep 12;352(9131):837-53
pubmed: 9742976
Nature. 2021 Dec;600(7889):383-385
pubmed: 34912079
Diabetes Care. 2013 Aug;36(8):2254-61
pubmed: 23690531
N Engl J Med. 2017 Aug 17;377(7):644-657
pubmed: 28605608
N Engl J Med. 2013 Oct 3;369(14):1317-26
pubmed: 23992601
N Engl J Med. 2012 Jul 26;367(4):319-28
pubmed: 22686416
J Diabetes. 2009 Mar;1(1):9-17
pubmed: 20923515
Nephrol Dial Transplant. 2006 Oct;21 Suppl 5:v4-8
pubmed: 16959791
Clin J Am Soc Nephrol. 2017 Dec 7;12(12):2032-2045
pubmed: 28522654
Diabetes Care. 2021 Jan;44(Suppl 1):S1-S2
pubmed: 33298409
N Engl J Med. 2008 Jun 12;358(24):2545-59
pubmed: 18539917
N Engl J Med. 2019 Jun 13;380(24):2295-2306
pubmed: 30990260
J Clin Epidemiol. 2017 Nov;91:47-53
pubmed: 28911999
Cardiovasc Diabetol. 2017 Mar 11;16(1):35
pubmed: 28284218
N Engl J Med. 2015 Nov 26;373(22):2117-28
pubmed: 26378978
Diabetes Res Clin Pract. 2020 Dec;170:108502
pubmed: 33065179
Nat Metab. 2020 Jul;2(7):572-585
pubmed: 32694793
Diabetes Care. 2021 Jan;44(Suppl 1):S73-S84
pubmed: 33298417
Biotechnol Bioeng. 2017 Dec;114(12):2696-2705
pubmed: 28842986
J Health Monit. 2021 Jun 16;6(2):19-35
pubmed: 35146307
Cardiovasc Diabetol. 2018 Feb 19;17(1):30
pubmed: 29458368
Lancet. 2021 Jul 10;398(10295):143-155
pubmed: 34186022
Diabetes Res Clin Pract. 2021 Jul;177:108870
pubmed: 34044026
Cardiovasc Diabetol. 2019 Mar 11;18(1):30
pubmed: 30857522
JAMA. 2019 Jan 1;321(1):69-79
pubmed: 30418475
N Engl J Med. 2020 Dec 03;383(23):2219-2229
pubmed: 33264825
Diabetes Res Clin Pract. 2020 Apr;162:108092
pubmed: 32109519
Cardiovasc Diabetol. 2018 Jun 8;17(1):83
pubmed: 29884191
Diabetes Res Clin Pract. 2022 Jan;183:109119
pubmed: 34879977
J Clin Epidemiol. 2017 Nov;91:23-30
pubmed: 28912002
Diabetes Care. 2021 Feb;44(2):549-555
pubmed: 33097560
Clin Diabetes. 2016 Oct;34(4):173-180
pubmed: 27766008
J Ind Microbiol Biotechnol. 2019 Oct;46(9-10):1297-1311
pubmed: 31317293
JAMA. 2021 Apr 13;325(14):1414-1425
pubmed: 33755728
N Engl J Med. 2021 Jan 14;384(2):117-128
pubmed: 33200892
N Engl J Med. 2021 Oct 14;385(16):1451-1461
pubmed: 34449189
BMJ Open Diabetes Res Care. 2020 Jan;8(1):
pubmed: 31958307
Eur Heart J. 2021 Sep 21;42(36):3599-3726
pubmed: 34447992
Lancet Diabetes Endocrinol. 2021 Nov;9(11):786-798
pubmed: 34619105
Cardiovasc Diabetol. 2020 Apr 17;19(1):47
pubmed: 32303223
BMJ. 2021 Jan 13;372:m4573
pubmed: 33441402
N Engl J Med. 2021 Dec 9;385(24):2252-2263
pubmed: 34449181
N Engl J Med. 2020 Oct 8;383(15):1425-1435
pubmed: 32966714
N Engl J Med. 2016 Jul 28;375(4):311-22
pubmed: 27295427
N Engl J Med. 2019 Nov 21;381(21):1995-2008
pubmed: 31535829
N Engl J Med. 2009 Jan 8;360(2):129-39
pubmed: 19092145
N Engl J Med. 2021 Jan 14;384(2):129-139
pubmed: 33200891
Obes Facts. 2017;10(5):483-492
pubmed: 29020674
Lancet. 2021 Mar 13;397(10278):971-984
pubmed: 33667417
N Engl J Med. 2015 Dec 3;373(23):2247-57
pubmed: 26630143
J Diabetes Sci Technol. 2019 May;13(3):575-583
pubmed: 30453761
Diabetes Care. 2018 Nov;41(11):2370-2376
pubmed: 30201847
JAMA. 2019 Sep 24;322(12):1155-1166
pubmed: 31536101
N Engl J Med. 2017 Sep 28;377(13):1228-1239
pubmed: 28910237
Cardiovasc Diabetol. 2021 Mar 31;20(1):75
pubmed: 33789663
Lancet. 2021 Nov 13;398(10313):1811-1824
pubmed: 34672967
Lancet. 2010 Jun 26;375(9733):2215-22
pubmed: 20609967
N Engl J Med. 2017 Aug 24;377(8):723-732
pubmed: 28605603
N Engl J Med. 2015 Jul 16;373(3):232-42
pubmed: 26052984
Handb Clin Neurol. 2014;126:3-22
pubmed: 25410210
J Clin Hypertens (Greenwich). 2011 Apr;13(4):244-51
pubmed: 21466619
N Engl J Med. 2021 Sep 2;385(10):896-907
pubmed: 34215025
JAMA. 2021 Apr 13;325(14):1403-1413
pubmed: 33625476
Diabetes Ther. 2021 Jan;12(1):143-157
pubmed: 33325008
N Engl J Med. 2008 Jun 12;358(24):2560-72
pubmed: 18539916
N Engl J Med. 2021 Mar 18;384(11):989
pubmed: 33567185
JAMA. 2022 Feb 8;327(6):534-545
pubmed: 35133415
Diabetes Care. 2019 Aug;42(8):1593-1603
pubmed: 31177185
Lancet. 2021 Aug 14;398(10300):583-598
pubmed: 34370970